REQUEST FOR PROPOSAL (RFP) COVID BIOMEDICAL RESEARCH INNOVATION FUND
the past several weeks, the Boettcher Foundation has closely monitored the
COVID-19 pandemic from the perspectives of crisis response, research, and
public health. Their learnings have propelled action from our Board of Trustees.
The Boettcher Foundation is announcing the Foundation’s release of up to $1 million in a rapid
response funding cycle to support biomedical research in Colorado.
Deadline for submissions: Friday, April 17, 2020 at 5 p.m
The National BiodefenseStrategy is.the
nation's plan for ensuring that the country is prepared for, responding to, and recovering from
health incidents such as the current COVID-19 Pandemic. As a partner in the Strategy, the Department of Energy (DOE)
contributes science and technology to support these efforts. This is not the first emerging
infectious disease event that the world will face, nor will it be the last. This is a call for your ideas
about how DOE and the National Labs might contribute resources to help address COVID-19
through science and technology efforts and collaborations.
The NIH is deeply concerned for the health and safety of people involved in NIH research, and about the effects on the biomedical enterprise in the areas affected by the HHS declared public health emergency for COVID-19. Due to the potential exceptional impact, we want to assure our recipient community that NIH will be doing our part to help you continue your research.
This is a rapidly evolving situation and we will provide updated guidance and information as it becomes available.
The Department of Health and Human Services has released multiple funding opportunities related to COVID-19
The Agency for Healthcare Research and Quality (AHRQ) intends to publish a new funding opportunity announcement in April using the R01 mechanism to support novel, high-impact studies evaluating health system and healthcare professional responsiveness to COVID-19. AHRQ will look to fund critical research focused on evaluating topics such as innovations and challenges encountered in the rapid expansion of telemedicine in response to COVID-19; effects on quality, safety, and value of health system response to COVID-19; and the role of primary care practices and professionals during the COVID-19 epidemic. AHRQ is particularly interested in understanding how digital health innovations contributed to health system and healthcare professional innovation and challenges and solutions to meeting the needs of vulnerable populations including older adults, people living with multiple chronic conditions, rural communities, and uninsured and underinsured populations.
AHRQ intends to publish a new funding notice in April allowing requests for urgent revision supplements to existing AHRQ grants and cooperative agreements to address health system responsiveness to COVID-19.
To enable a rapid-response to the COVID-19 outbreak, Biomedical Advanced Research and Development Authority (BARDA) has repurposed its existing TechWatch program to focus on COVID-19 medical countermeasures. These CoronaWatch submissions and meetings aim to give innovators and innovative companies a government-wide platform to discuss their ideas with U.S. government experts, and seek partnership opportunities with a wide range of potential federal partners. BARDA is particularly interested in products and technologies that have progressed into or beyond non-clinical trials, have established large-scale cGMP manufacturing capability, or utilize an approved platform. Information regarding diagnostics, therapeutics, vaccines, and other products or technologies relevant to addressing this outbreak are sought.
In response to the COVID-19 pandemic, the Novartis US Foundation has established the US COVID-19 Community Response Fund to support local initiatives and communities in the US impacted by the outbreak. The fund will provide up to USD $5 million total over a one-year period for immediate response and recovery efforts related to the pandemic. Programs must support one or more of the three stated objectives: Strengthening local and national healthcare infrastructure to meet increased demand and protect frontline health workers, establishing digital platforms for COVID-19 related data collection, remote delivery of healthcare and effective dissemination of important public health information, or creating or enhancing new community health programs specific to the pandemic response. R&D efforts related to COVID-19 are not eligible.
The Gates Foundation is seeking innovative solutions that accelerate the improvement of coverage, reach, efficiency, and effectiveness of mass health campaigns that deliver health products or services in low-and middle-income countries, specifically through improved planning/microplanning and focus on unreached populations. Specifically, they are looking for innovations in approaches, practices, or tools that dramatically improve the planning/microplanning that will lead to improved effectiveness of campaigns. The Foundation is also looking for innovative tools and technologies to more effectively identify and reach the most vulnerable populations when countries are designing and implementing mass campaigns
The CDC will support accelerated planning and operational readiness for COVID-19 preparedness and response, as well as develop tools and strategies, provide technical assistance and program support, and ensure ongoing communication and coordination among federal, state, local, tribal, and territorial public health agencies and partners throughout the response.
View the link below for available COVID funding from the CDC.
As the pandemic continues, we are seeing additional COVID-19-related research funding opportunities become available from many sponsors and sources. The Office of Research Development and Education created a new website consolidating these opportunities, which is updated daily. There you will find information on sponsors, funding opportunities and projects, and links to detailed information, as well as deadlines for applications.
As the COVID-19 situation continues to develop, it’s critically important that researchers, who are learning about the virus and pursuing science-based solutions to the global coronavirus pandemic, can find the funding they need. With this in mind, GrantForward is proud to provide free access to a list of funding opportunities in the area of COVID-19.
The list of available coronavirus-related funding calls and other support for researchers, non-profit organizations and commercial organizations, with all relevant information, will be updated on a daily basis.
COVID-19’s impacts are reaching every corner of the world. We must stand together. By raising awareness of these funding sources, we are honored to do our part to help researchers expand their scholarly efforts to understand and contend with this global pandemic. If you are aware of other COVID-19 research grants, we would appreciate you sharing them with us. Click here to send us an email.
Harrington Discovery Institute at University Hospitals in Cleveland, Ohio,
has issued a transatlantic call for proposals for new treatments, pursuant to
announced major initiative to support the global fight against novel
Coronavirus and potential future pandemic events. Harrington Discovery
Institute (HDI) will provide successful applicants with grant funding and
expert guidance and oversight in all aspects of drug/therapeutics development,
while taking no rights to intellectual property, which is retained by the award
recipient and their institution.
The Defense Advanced Research Projects Agency (DARPA) encourages researchers to submit COVID-19 related proposals through its standard Broad Agency Announcement (BAA) funding mechanism in the Biological Technologies Office or Defense Sciences Office. These BAA proposals are continuously open and reviewed.
Newton Award for Transformative Ideas during the COVID-19 Pandemic:
This award will be presented to a single investigator or team of up to two investigators that develops a “transformative idea” to resolve challenges, advance frontiers, and set new paradigms in areas of immense potential benefit to DoD and the nation at large. Proposals should aim to produce novel conceptual frameworks or theory-based approaches that present disruptive ways of thinking about fundamental scientific problems that have evaded resolution, propose new, paradigm-shifting scientific directions, and/or address fundamental and important questions that are argued to be undervalued by the scientific community. Approaches can include analytical reasoning, calculations, simulations, and thought experiments. While data collection and production are therefore allowed, all supporting data should be generated without the use of laboratory-based experimentation or instrumentation.
The Defense Logistics Agency (DLA) seeks white papers for Prototype Other Transaction Agreement (OTA) funding to support COVID-19 prototypes in two areas: i) Personal Protective Equipment (PPE) Re-Use and Decontamination and ii) Prototype PPE: N95 Equivalent Masks that can be rapidly produced with alternate materials or methods. DLA anticipates funding of $1 million for multiple prototypes. White papers will be reviewed as they are received through the 5/4/2020 deadline.
DoD JATF is seeking input to shape its COVID-19 funding decisions focused on the accelerated ramp-up of production capacity for critical healthcare products such as masks, ventilators, test kits, and vaccines. JATF Focus Areas: 1) Combating Spread, 2) Welfare of Citizens, 3) Readiness, 4) Logistics, 5) Industrial base impacts, 6) Medical, 7) Other
The Army's Medical Technology Enterprise Consortium (MTEC) has posted an announcement of the possibility of RPPs to rapidly accelerate development of technology to detect exposure, prevent, contain and treat COVID-19 and future emerging threats in the following areas:
1) Point-of-care diagnostic that provides rapid and accurate determination on exposure to COVID-19.
2) Prophylactic(s)/Therapeutic(s) that can prevent and/or treat in a rapid manner (few hours to 2 days) potentially in a non-hospital environment. Repurposing FDA-approved drugs/biologics for prevention/treatment of COVID-19 or testing of drugs/biologics that have already demonstrated safety in humans for the prevention/treatment of COVID-19 are preferred.
3) Disease predictive modeling that provides early warning through data capture from several different streams of data to include social media and artificial intelligence (AI) parameter decision tools that would provide actionable information to medical service providers and command structures.
4) Patient monitoring, tracking, and management system for in-home or non-hospital environment patient tele-health services to include interface into the Cerner electronic health record.
The Army Futures Command’s (AFC) Army Applications Laboratory (AAL) has expressed significant interest in new technologies to support the Army’s COVID-19 response including innovative medical equipment, therapeutics, diagnostics, and vaccines. AAL has set up a webpage for organizations to schedule a brief phone call to discuss their ideas for technologies that support diagnosis, care, and the protection of healthcare providers, active duty service members, their families, and communities from COVID-19.
The Army's Medical Technology Enterprise Consortium (MTEC) has posted a pre-announcement for a Request for Project Proposals (RPP) to rapidly develop and deploy the National Emergency Telecritical Care Network (NETCCN).The program will support the extension of high-quality intensive care to traditional (e.g. critical access hospitals and clinics) and non-traditional and temporary healthcare facilities (e.g. field hospitals and gymnasiums) which lack adequate critical care expertise and resources necessary for care of COVID-19-related illnesses. This upcoming RPP will focus on enhanced development of integrated technologies and clinical workflows to establish and rapidly scale virtual wards. Enhanced white papers should specifically address providing EXISTING technologies (mobile communications, clinician-facing web portal/app, real-time documentation, cloud-based information storage...) available for other use cases that can be rapidly adapted to establish the NETCCN.
Program Element A.28 "Rapid Response and Novel Research in Earth Science" (RRNES) of Research Opportunities in Space and Earth Sciences (ROSES) 2020 provides an opportunity to propose investigations making innovative use of NASA satellite data to address regional-to-global environmental, economic, and/or societal impacts of the COVID-19 pandemic. Potential proposals may address R&A-related topics more fundamental in underlying physical and/or biological sciences (including possible connections to socioeconomic activities) and/or ASP-related topics characterizing impacts of decisions or efforts to inform decision makers on regional-to-global levels in their responses to mitigate the impacts of the disease. While proposed studies must use NASA satellite data and information products as a primary source of information and research tools, they may also utilize remote sensing data and products from government agencies, international, or commercial sources. Studies utilizing Artificial Intelligence (AI) techniques including Machine Learning (ML) and Deep Learning (DL) are encouraged. Rolling deadline.
Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s
medical and/or scientific strategies. A request for proposal (RFP) will be released in the coming weeks, which will include instructions for organizations to submit COVID-19 related grant requests.